Loading...
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies
OBJECTIVE: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. This post hoc analysis evaluated patients receiving tofacitinib monotherapy or combination therapy, as well as those who switched from monotherapy to combination therapy (mono→combo) or vice versa (co...
Na minha lista:
| Udgivet i: | RMD Open |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5761286/ https://ncbi.nlm.nih.gov/pubmed/29435359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000491 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|